Company: CNCKW
Filing Date: 2025-03-10
Form Type: 6-K
Source: 0001213900-25-022287
Chunk: 0

Company: Coincheck Group N.V.
Filing Date: 2025-03-10
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2025

Commission File Number: 001-42438

COINCHECK GROUP N.V.

(Translation of registrant’s name into English)

Apollolaan 151

1077 AR Amsterdam

The Netherlands

(Address of principal executive offices)</div>

Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒
Form 40-F ☐

Coincheck Group N.V. (“Coincheck Group” or the “Company”)
is furnishing this Report on Form 6-K to provide the below updates.

Extraordinary General Meeting

On March 10, 2025, Coincheck Group convened its previously announced
extraordinary general meeting of shareholders. The notice of the extraordinary general meeting of shareholders and related materials were
posted to Coincheck Group’s website (https://www.coincheckgroup.com/) under “Governance—General Meetings.” Coincheck
Group does not incorporate the information contained on, or accessible through, Coincheck Group’s website or related social media
channels into this Report on Form 6-K.

All three proposals were adopted pursuant to a vote of shareholders
(as of the record date of the close of business on February 10, 2025), as set forth below, based on a total of 127,846,723 votes cast:

Authorization of the board for a period of eighteen months starting March 10, 2025 to issue up to 25,000,000 ordinary shares and/or grant rights to subscribe for such shares (the “Issuance Authorization”)

|                  |     |   Votes for |     | Votes against |     | Votes abstain |
| Number of shares |     | 127,781,972 |     |        61,451 |     |         3,300 |
| Percentage       |     |      99.95% |     |         0.05% |     |             - |

Authorization of the board for a period of eighteen months starting March 10, 2025 to restrict or exclude pre-emptive rights accruing to shareholders